Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

Pertussis (whooping cough) is a respiratory disease caused primarily by Bordetella
pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in …

Despite the implementation of effective paediatric vaccination programmes, pertussis
remains a global health problem. Disease epidemiology has changed over time, shifting …

Background In the course of the SARS-CoV-2 pandemic, multiple vaccines were developed.
Little was known about reactogenicity and safety in comparison to established vaccines, eg …

Background In Korea, there are no surveillance programs for vaccines that are not included
in the national immunization program (NIP), and vaccine safety monitoring in the adult …

Pertussis is underdiagnosed and underreported in adults and patients with underlying
conditions. Patients with chronic obstructive pulmonary disease (COPD) may be at …

Despite the development of new biological and synthetic targeted therapies, methotrexate
remains one of the most commonly used immunomodulatory drugs in rheumatology …

Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …

Abstract Background In the United States, persons≥ 11 years are recommended to receive
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …

Adult pertussis vaccination is increasingly recommended to control pertussis in the
community. However, there is little data on the duration and kinetics of immunity to pertussis …